Table 2.
Baseline Characteristics of Intervention and Control Group Patients
| Characteristic | Intervention (N = 809) | Control (N = 727) |
|---|---|---|
| N (%) or mean ± SD | ||
| Age (years) as of 6/1/18 | 67.1 ± 9.2 | 67.8 ± 12.7 |
| Male | 782 (97%) | 707 (97%) |
| Race* | ||
| White | 550 (68%) | 540 (74%) |
| Black | 150 (19%) | 89 (12%) |
| Asian | 29 (4%) | 26 (4%) |
| American Indian/Alaskan Native | 8 (1%) | 7 (1%) |
| Hawaiian/Pacific Islander | 20 (2%) | 11 (2%) |
| Missing | 60 (7%) | 61 (8%) |
| Ethnicity | ||
| Hispanic or Latino | 70 (9%) | 64 (9%) |
| Not Hispanic or Latino | 702 (87%) | 626 (86%) |
| Missing | 37 (5%) | 37 (5%) |
| Most recent hemoglobin A1c in the last 8 months (%) | 9.1 ± 1.5 | 8.9 ± 1.3 |
| Mean systolic blood pressure over the last 8 months (mmHg) | 136.2 ± 13.4 | 137.7 ± 15.2 |
| Most recent systolic blood pressure in the last 8 months (mmHg) | 137.2 ± 17.5 | 139.6 ± 18.9 |
| On insulin | 385 (48%) | 255 (35%) |
| On statin | 603 (75%) | 470 (65%) |
| Classes of antihypertensive medications | 2.4 ± 1.2 | 2.2 ± 1.3 |
| Primary care in-person visits in past 8 months | 3.4 ± 3.1 | 3.2 ± 3.4 |
| Primary care phone visits in past 8 months | 0.7 ± 1.2 | 0.7 ± 1.5 |
| Nurse Case Manager in-person visits in past 8 months | 0.2 ± 0.7 | 0.2 ± 0.8 |
| Nurse Case Manager phone visits in past 8 months | 0.3 ± 0.9 | 0.3 ± 0.9 |
| Endocrinology in-person visits in past 8 months | 0.3 ± 0.8 | 0.2 ± 0.8 |
*Patients can have more than 1 race listed, so these do not add to 100%